2019
DOI: 10.1002/jia2.25376
|View full text |Cite
|
Sign up to set email alerts
|

HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI‐PMTCT study

Abstract: Introduction Published data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors. Methods This cross‐sectional study was conducted as part of a baseline assessment for the CQI‐PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous qual… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
29
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(32 citation statements)
references
References 29 publications
2
29
1
Order By: Relevance
“…We additionally report that approximately 80% retained in this cohort had durable VLS to 24 months, which will confer increased benefit in preventing HIV transmission during breastfeeding and subsequent pregnancies, as well as preservation of health in mothers. However, the proportion of women achieving durable VLS in our study is higher than that reported in South Africa (70% (<50 copies/mL) at 12 months and 56% at 36-60 months (median 44 months post-partum)) [18] and in Kenya (67% (<1000 copies/mL) at 12months) [19]. These differences may be explained by diverse proportions of retention and loss to follow-up across these different settings, including that women retained to 24 months in our study may not reflect population-level VLS among all post-partum Malawian women.…”
Section: Plos Onecontrasting
confidence: 82%
“…We additionally report that approximately 80% retained in this cohort had durable VLS to 24 months, which will confer increased benefit in preventing HIV transmission during breastfeeding and subsequent pregnancies, as well as preservation of health in mothers. However, the proportion of women achieving durable VLS in our study is higher than that reported in South Africa (70% (<50 copies/mL) at 12 months and 56% at 36-60 months (median 44 months post-partum)) [18] and in Kenya (67% (<1000 copies/mL) at 12months) [19]. These differences may be explained by diverse proportions of retention and loss to follow-up across these different settings, including that women retained to 24 months in our study may not reflect population-level VLS among all post-partum Malawian women.…”
Section: Plos Onecontrasting
confidence: 82%
“…While LTFU negatively impacts our ability to determine incidence of MTCT, it is an expected feature of pragmatic feasibility studies and consistent with postnatal follow-up patterns in the DRC. 18 Wealth quartiles were calculated from a principal component analysis including the following variables: people per household room, number of beds in household, number of radios in household, number of televisions in household, number of phones in household, number of refrigerators in household, ownership of a car, presence/absence of electricity in household, cooking with electricity, cooking with wood, and private water source.…”
Section: Discussionmentioning
confidence: 99%
“…While LTFU negatively impacts our ability to determine incidence of MTCT, it is an expected feature of pragmatic feasibility studies and consistent with postnatal follow-up patterns in the DRC. 18 Fourth, supply chain disruption prevented us from completing planned laboratory comparisons of HBeAg and viral load testing on DBS versus venous blood in-country. The COVID-19 pandemic bears some responsibility for these challenges, but nascent HBV laboratory reagent supply chains are also to blame.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The UNAIDS 90-90-90 target translates to 90% of all persons to be tested for HIV, 90% of those infected should be on treatment, and 90% of those on treatment should have their viral load suppressed to undetectable levels. In this scheme, treatment is expected to act as a prevention tool, since the chances of transmission is highly reduced when viral load is undetectable [2][3][4][5]. Combination antiretroviral therapy (cART) is the gold standard for the management of HIV infections.…”
mentioning
confidence: 99%